Mycosis fungoides primary prevention

Jump to navigation Jump to search

Mycosis fungoides Microchapters


Patient Information


Historical Perspective




Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


CT Scan


Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Mycosis fungoides primary prevention

All Images
Echo and Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides primary prevention

CDC on Mycosis fungoides primary prevention

Mycosis fungoides primary prevention in the news

Blogs on Mycosis fungoides primary prevention

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]


  • There are no established measures for the secondary prevention of mycosis fungoides but recommended that effective measures for the secondary prevention of mycosis fungoides is follow up patients with active or progressive disease, every 4–6 weeks.

Primary Prevention


  1. A. S. Whittemore, E. A. Holly, I. M. Lee, E. A. Abel, R. M. Adams, B. J. Nickoloff, L. Bley, J. M. Peters & C. Gibney (1989). "Mycosis fungoides in relation to environmental exposures and immune response: a case-control study". Journal of the National Cancer Institute. 81 (20): 1560–1567. PMID 2795681. Unknown parameter |month= ignored (help)
  2. Hall WW, Liu CR, Schneewind O, Takahashi H, Kaplan MH, Röupe G, Vahlne A (July 1991). "Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides". Science. 253 (5017): 317–20. PMID 1857968.
  3. S. K. Ghosh, J. T. Abrams, H. Terunuma, E. C. Vonderheid & E. DeFreitas (1994). "Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma". Blood. 84 (8): 2663–2671. PMID 7522638. Unknown parameter |month= ignored (help)

Template:WH Template:WS